Efficacy of everolimus-eluting stent implantation in patients with small coronary arteries: outcomes of 3-year clinical follow-up

被引：0
|
作者：
Ishikawa, M. [1 ]
Yano, H. [2 ]
Horinaka, S. [3 ]
Ishimitsu, T. [3 ]
机构：
[1] Dokkyo Med Univ, Nikko Med Ctr, Mibu, Tochigi, Japan
[2] Nasu Red Cross Hosp, Cardiol, Otawara, Tochigi, Japan
[3] Dokkyo Med Univ Hosp, Cardiol, Mibu, Tochigi, Japan
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3454
引用
收藏
页码：678 / 678
页数：1
相关论文
共 50 条
  • [41] Everolimus-Eluting Versus Biolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus
    Gyldenkerne, Christine
    Olesen, Kevin K. W.
    Jensen, Lisette O.
    Junker, Anders
    Veien, Karsten T.
    Terkelsen, Christian J.
    Kristensen, Steen D.
    Thim, Troels
    Jensen, Svend E.
    Raungaard, Bent
    Aaroe, Jens
    Kahlert, Johnny
    Villadsen, Anton B.
    Botker, Hans Erik
    Christiansen, Evald H.
    Maeng, Michael
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (05): : 671 - 677
  • [42] Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis 3-Year Follow-Up of the RIBS V Clinical Trial
    Alfonso, Fernando
    Jose Perez-Vizcayno, Maria
    Garcia del Blanco, Bruno
    Otaegui, Imanol
    Masotti, Monica
    Zueco, Javier
    Velaquez, Maite
    Sanchis, Juan
    Garcia-Touchard, Arturo
    Lazaro-Garcia, Rosa
    Moreu, Jose
    Bethencourt, Armando
    Cuesta, Javier
    Rivero, Fernando
    Cardenas, Alberto
    Gonzalo, Nieves
    Jimenez-Quevedo, Pilar
    Fernandez, Cristina
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (12) : 1246 - 1255
  • [43] Coronary vasomotion one year after drug eluting stent implantation: comparison of everolimus-eluting and paclitaxel-eluting coronary stents
    Hamilos, M.
    Ribichini, F.
    Ostojic, M.
    Ferrero, V.
    Orlic, D.
    Vassanelli, C.
    Karanovic, N.
    Cuisset, T.
    Vardas, P.
    Wijns, W.
    EUROPEAN HEART JOURNAL, 2011, 32 : 202 - 202
  • [44] Poor Progression of in-Stent Neoatherosclerosis in Patients With Everolimus-Eluting Stent Implantation: Coronary Angioscopic Observation
    Ichikawa, Minoru
    Yoshima, Shohei
    Takei, Yoshizumi
    Kawai, Kenji
    Oshita, Takeshi
    Fukuda, Kenji
    Takagi, Takashi
    Kijima, Yoshiyuki
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
  • [45] Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis With Everolimus-Eluting Stents
    Lee, Michael S.
    Yang, Tae
    Mahmud, Ehtisham
    Park, Kyung Woo
    Kim, Hyo-Soo
    Kim, Moo Hyun
    Dangas, George
    Hermiller, James
    Krucoff, Mitchell
    Rutledge, David
    JOURNAL OF INVASIVE CARDIOLOGY, 2014, 26 (09): : 420 - 426
  • [46] Five-Year Clinical Outcomes of NOBORI Biolimus-Eluting Stent versus XIENCE Everolimus-Eluting Stent in Diabetic Patients
    Tanaka, Yuichi
    Kuramitsu, Shoichi
    Hiromasa, Takashi
    Hyodo, Makoto
    Shirai, Shinichi
    Ando, Kenji
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B250 - B250
  • [47] Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: 3 Year Follow-Up from the COMPARE II trial
    Smits, Pieter C.
    Vlachojannis, Georgios J.
    Hofma, Sjoerd H.
    Togni, Mario
    Vazquez, Nicolas
    Valdes, Mariano
    Voudris, V.
    Slagboom, Ton
    Goy, Jean-Jacques
    Vuillomenet, A. G.
    Serra, Antonio
    Trillo, Ramiro
    den Heijer, Peter
    van der Ent, Martin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B170 - B170
  • [48] Long-term outcomes after treatment of bare-metal stent restenosis with paclitaxel-coated balloon catheters or everolimus-eluting stents: 3-year follow-up of the TIS clinical study
    Pleva, Leos
    Kukla, Pavel
    Zapletalova, Jana
    Hlinomaz, Ota
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (06) : E416 - E424
  • [49] Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
    Vlachojannis, Georgios J.
    Smits, Pieter C.
    Hofma, Sjoerd H.
    Togni, Mario
    Vazquez, Nicolas
    Valdes, Mariano
    Voudris, Vassilis
    Puricel, Serban
    Slagboom, Ton
    Goy, Jean-Jacques
    den Heijer, Peter
    van der Ent, Martin
    EUROINTERVENTION, 2015, 11 (03) : 272 - 279
  • [50] Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis with the XIENCE V Everolimus-Eluting Stent
    Lee, Michael
    Yang, Tae
    Mahmud, Ehtisham
    Park, Kyung Woo
    Kim, Hyo-Soo
    Kim, Moo Hyun
    Dangas, George
    Hermiller, James, Jr.
    Krucoff, Mitchell
    Rutledge, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B140 - B140
12345